| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/05/1999 | US5856084 Recombinant dna molecules which code for polypeptides having specificity towards a hepatitis b viral antigen. |
| 01/05/1999 | US5855891 Ichimeric papillomavirus-like particles |
| 01/05/1999 | US5855867 Radiological imaging |
| 01/05/1999 | CA2046956C O-methyl derivatives of azithromycin a, process and intermediate for their preparation, and use thereof in the preparation of pharmaceuticals |
| 01/03/1999 | CA2236462A1 Murc |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2236459A1 Novel compounds |
| 01/01/1999 | CA2236452A1 Gida1 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236435A1 Gida2 |
| 01/01/1999 | CA2236431A1 Gidb |
| 01/01/1999 | CA2236425A1 Gida1 |
| 01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
| 12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
| 12/30/1998 | WO1998058933A1 Cephalosporin compounds, use thereof and intermediate compounds of the same |
| 12/30/1998 | WO1998058931A1 PROCESS FOR PRODUCING β-LACTAM DERIVATIVES |
| 12/30/1998 | WO1998058928A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 12/30/1998 | WO1998058677A1 Pharmaceutical formulations containing voriconazole |
| 12/30/1998 | WO1998058675A1 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent |
| 12/30/1998 | WO1998058670A1 Methods of immunizing adults using anti-meningococcal vaccine compositions |
| 12/30/1998 | WO1998058668A2 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae |
| 12/30/1998 | WO1998058663A1 Use of proteolytic enzymes for influencing cytokines |
| 12/30/1998 | WO1998044944A3 Stabilized human papillomavirus formulations |
| 12/30/1998 | WO1998043670A3 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 12/30/1998 | EP0887416A2 Human AFC1 |
| 12/30/1998 | EP0887415A2 Human RCE1 |
| 12/30/1998 | EP0887413A2 Histidine kinase |
| 12/30/1998 | EP0887411A2 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Streptococcus pneumoniae |
| 12/30/1998 | EP0887410A2 DNA encoding a plasminogen activating protein |
| 12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
| 12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
| 12/30/1998 | EP0887352A1 Carbapenem derivatives and antimicrobials |
| 12/30/1998 | EP0886677A1 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound |
| 12/30/1998 | EP0886651A1 Persephin and related growth factors |
| 12/30/1998 | EP0886646A1 Novel compounds |
| 12/30/1998 | EP0886635A1 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity |
| 12/30/1998 | EP0886520A1 Caffeine and clemastine for treating respiratory disorders |
| 12/30/1998 | EP0766688A4 Synthesis of oligonucleotides |
| 12/30/1998 | EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 12/30/1998 | EP0661999B1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 12/30/1998 | EP0591384B1 Attenuated revertant serotype 1 marek's disease vaccine |
| 12/30/1998 | EP0539522B1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease |
| 12/30/1998 | EP0522084B1 Antiviral compositions and method for their use |
| 12/30/1998 | CN1203630A 治疗和诊断组合物 Therapeutic and diagnostic compositions |
| 12/30/1998 | CN1203600A Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| 12/30/1998 | CN1203596A Furan-and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of replication of HIV-1 and HIV-1 mutants |
| 12/30/1998 | CN1203590A Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 12/30/1998 | CN1203530A Treatment of CNS effect of HIV with VX-475, alone or in combination with AZT or 3TC |
| 12/30/1998 | CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor |
| 12/30/1998 | CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate |
| 12/30/1998 | CN1203275A Processes for preparation of Marek's disease virus using continuous mammalian cell lines |
| 12/30/1998 | CN1203232A 2-carboxymethyl-5-(5-fluoro cyti midine-1-yl) 1,3-oxythiapentane and its derivatives |
| 12/30/1998 | CN1203224A Process for preparation of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate |
| 12/30/1998 | CA2594375A1 Bovine adenovirus type 3 genome |
| 12/30/1998 | CA2294453A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 12/30/1998 | CA2294348A1 Vaccines containing bordetella pertussis antigen |
| 12/30/1998 | CA2294283A1 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent |
| 12/29/1998 | US5854416 Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor |
| 12/29/1998 | US5854289 Guanylhydrazones and their use to treat inflammatory conditions |
| 12/29/1998 | US5854280 Antifungal sordaridin derivatives |
| 12/29/1998 | US5854242 Benzoxazine antimicrobial agents |
| 12/29/1998 | US5854234 Amidino dervatives useful as nitric oxide synthase inhibitors |
| 12/29/1998 | US5854219 9-N-ethenyl derivatives of 9(S)-erythromycylamine |
| 12/29/1998 | US5854213 Antifungal cyclohexapeptides |
| 12/29/1998 | US5854055 Recombinant mycobacteria |
| 12/29/1998 | US5854038 Localization of a therapeutic agent in a cell in vitro |
| 12/29/1998 | US5854020 TCSTS polynucleotides |
| 12/29/1998 | US5854007 Process for producing GM1 specific antibodies |
| 12/29/1998 | US5853987 Decorin binding protein compositions and methods of use |
| 12/29/1998 | US5853732 Pharmaceutical compositions containing kukui nut oil |
| 12/29/1998 | US5853725 Prevention and treatment of retroviral disease |
| 12/29/1998 | US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 12/29/1998 | US5853003 Treatment and diagnosis of respiratory disorders using fluorocarbon liquids |
| 12/29/1998 | CA2152817C Novel pyridone carboxylic acid derivatives |
| 12/29/1998 | CA2129554C Recombinant antibodies specific for tnf-.alpha. |
| 12/29/1998 | CA2064029C Use of mycobacterium vaccae in the prevention of aids |
| 12/29/1998 | CA1340297C Conjugation of polymer to colony stimulating factor-1 |
| 12/26/1998 | CA2235778A1 Novel glmu |
| 12/24/1998 | DE19726255A1 Beeinflussung von Cytokinen durch proteolytische Enzyme Influence of cytokines by proteolytic enzymes |
| 12/24/1998 | DE19722846A1 Leukotrien-B¶4¶-Derivate, insbesondere 7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular 7-methylcyclohexyl-LTB¶4¶ antagonists |
| 12/24/1998 | CA2234418A1 Human afc1 |
| 12/24/1998 | CA2234402A1 Human rce1 |
| 12/23/1998 | WO1998057994A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 12/23/1998 | WO1998057976A1 Secreted proteins and polynucleotides encoding them |
| 12/23/1998 | WO1998057967A1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same |
| 12/23/1998 | WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 12/23/1998 | WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 12/23/1998 | WO1998057931A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| 12/23/1998 | WO1998057660A1 Adjuvant compositions for vaccines |
| 12/23/1998 | WO1998057659A1 Adjuvant compositions for vaccines |
| 12/23/1998 | WO1998057657A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
| 12/23/1998 | WO1998057637A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| 12/23/1998 | WO1998057555A1 Fermentation products and method for preventing food poisoning |
| 12/23/1998 | WO1998042868A3 Screening method for proline-rich proteins |
| 12/23/1998 | EP0885966A2 Novel compouds |
| 12/23/1998 | EP0885965A2 Histidine kinase polypeptides |
| 12/23/1998 | EP0885963A2 Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide |
| 12/23/1998 | EP0885960A2 G-protein coupled receptor (H7TBA62) |
| 12/23/1998 | EP0885903A2 Nucleic acid encoding streptococcus pheumoniae response regulator |
| 12/23/1998 | EP0885902A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |